Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent GBM”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchActive Not RecruitingNCT04656535
What this trial is testing

AB154 Combined With AB122 for Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Yale University 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07831187
What this trial is testing

Entacapone Plus Bevacizumab for Glioblastoma at First Recurrence

Who this might be right for
Glioblastoma
First Affiliated Hospital of Wenzhou Medical University 96
Testing effectiveness (Phase 2)WithdrawnNCT02348255
What this trial is testing

NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse

Who this might be right for
Adult Brain GlioblastomaRecurrent Adult Brain Neoplasm
University of California, Davis
Not applicableStudy completedNCT04143425
What this trial is testing

Response Prediction for Anti-angiogenic Treatment in Recurrent Glioblastoma

Who this might be right for
Adult GlioblastomaMagnetic Resonance ImagingBevacizimab
Ho Sung Kim 15
Not applicableUnknownNCT03903419
What this trial is testing

Feasibility Study of 68Ga-PSMA PET-CT and 18F-FDOPA PET-CT in Glioblastoma's Patients

Who this might be right for
Glioblastomas
Centre Leon Berard 16
Testing effectiveness (Phase 2)WithdrawnNCT01115036
What this trial is testing

A Panobinostat Presurgery

Who this might be right for
Recurrent Glioblastoma
Duke University
Testing effectiveness (Phase 2)Ended earlyNCT02743078
What this trial is testing

Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma

Who this might be right for
GlioblastomaGliomaGliosarcoma
RTOG Foundation, Inc. 3
Early research (Phase 1)Study completedNCT02010606
What this trial is testing

Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma

Who this might be right for
GlioblastomaGlioblastoma MultiformeGlioma+2 more
Cedars-Sinai Medical Center 39
Not applicableStudy completedNCT03997617
What this trial is testing

Personalized Functional Profiling in Metastatic Gastrointestinal Cancer or Recurrent Glioblastoma Patients in Luxembourg.

Who this might be right for
Oncology
Luxembourg Institute of Health 57
Testing effectiveness (Phase 2)Study completedNCT00939991
What this trial is testing

Suberoylanilide Hydroxamic Acid (SAHA), Bevacizumab, Daily Temozolomide for Recurrent Malignant Gliomas

Who this might be right for
Brain TumorGlioblastoma
Katy Peters 48
Early research (Phase 1)Looking for participantsNCT05769660
What this trial is testing

Evaluate Safety and Efficacy of BEY1107 in Combination with Temozolomide in Patients with Recurrent or Progressive Glioblastoma Multiforme (GBM)

Who this might be right for
Glioblastoma Multiforme
BeyondBio Inc. 12
Early research (Phase 1)Study completedNCT01316809
What this trial is testing

AZD8055 for Adults With Recurrent Gliomas

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaAnaplastic Oligodendroglioma+2 more
National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Ended earlyNCT01113463
What this trial is testing

TPI 287 in Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain Cancer
M.D. Anderson Cancer Center 17
Testing effectiveness (Phase 2)Study completedNCT03744026
What this trial is testing

Safety and Efficacy of Transient Opening of the Blood-brain Barrier (BBB) With the SonoCloud-9

Who this might be right for
Glioblastoma, Adult
CarThera 38
Early research (Phase 1)Study completedNCT01131234
What this trial is testing

Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+49 more
National Cancer Institute (NCI) 20
Early research (Phase 1)Study completedNCT00539344
What this trial is testing

A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma

Who this might be right for
Recurrent or Progressive Malignant Glioma
Angiochem Inc 63
Early research (Phase 1)Active Not RecruitingNCT03749187
What this trial is testing

BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas

Who this might be right for
GlioblastomaIDH1 Gene MutationIDH2 Gene Mutation+7 more
University of California, San Francisco 78
Large-scale testing (Phase 3)Active Not RecruitingNCT05118776
What this trial is testing

Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rGBM

Who this might be right for
Recurrent Glioblastoma
Ascletis Pharmaceuticals Co., Ltd. 136
Very early researchActive Not RecruitingNCT03893487
What this trial is testing

Fimepinostat in Treating Brain Tumors in Children and Young Adults

Who this might be right for
Diffuse Intrinsic Pontine GliomaRecurrent Anaplastic AstrocytomaRecurrent Glioblastoma+2 more
Sabine Mueller, MD, PhD 30
Testing effectiveness (Phase 2)Ended earlyNCT04915404
What this trial is testing

Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV)

Who this might be right for
Recurrent Glioblastoma Multiforme
WPD Pharmaceuticals Sp. z o.o. 5
Next Page